Atlas Trials

3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial

Clinical trial NCT01563354 · COMPLETED

Trial details

NCT number
NCT01563354
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Carcinoma of the Lung and Thymus
Start date
2013-08-16
Primary completion
2020-02-10
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.